Difference between revisions of "Hodi FS, et al. N. Engl. J. Med. (2010) cited as Ref 642 in DOI: 10.1038/s41392-020-0110-5 (Q9905)"
Jump to navigation
Jump to search
(Created claim: PubMed ID (P140): 20525992, #quickstatements; #temporary_batch_1590001671040) |
(Created claim: Page(s) (P105): 711-723, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
(4 intermediate revisions by the same user not shown) | |||||||||||||||
Property / Publication Date | |||||||||||||||
+ | 2010
| ||||||||||||||
Property / Publication Date: 2010 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Published In Name String | |||||||||||||||
+ | N. Engl. J. Med. | ||||||||||||||
Property / Published In Name String: N. Engl. J. Med. / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Volume | |||||||||||||||
+ | 363 | ||||||||||||||
Property / Volume: 363 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / title | |||||||||||||||
+ | Improved survival with ipilimumab in patients with metastatic melanoma (English) | ||||||||||||||
Property / title: Improved survival with ipilimumab in patients with metastatic melanoma (English) / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Page(s) | |||||||||||||||
+ | 711-723 | ||||||||||||||
Property / Page(s): 711-723 / rank | |||||||||||||||
+ | Normal rank |
Latest revision as of 15:47, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Hodi FS, et al. N. Engl. J. Med. (2010) cited as Ref 642 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Hodi FS
0 references
2010
0 references
N. Engl. J. Med.
0 references
363
0 references
Improved survival with ipilimumab in patients with metastatic melanoma (English)
0 references
711-723
0 references